From the creators of the IL-2 series, Korea. IL-2 Series is the latest entry in the historical flight combat simulator franchise covering a unique era in aviation-based combat that time almost forgot.

Jaime Tugayev is the News Editor at DualShockers, where he covers gaming news, reviews, features, guides, and major industry updates. He has been writing professionally since 2013 and covering games ...

Nicknamed “The Flying Tank,” the Il-2 Sturmovik was the Soviet Union’s most feared ground-attack aircraft in WWII. First deployed in 1941, its armored design allowed it to survive fierce enemy fire.

Jaime Tugayev is the News Editor at DualShockers, where he covers gaming news, reviews, features, guides, and major industry updates. He has been writing professionally since 2013 and covering games ...

There are conflicts that have been seen so many times in gaming that they almost become background noise. World War 2 in particular almost has become a default setting, something that may be robbing ...

From the creators of the IL-2 series, Korea. IL-2 Series is the latest entry in the historical flight combat simulator franchise covering a unique era in aviation-based combat that time almost forgot.

Initial results from a first-in-human phase 1 study of SNS-101 (pH-selective anti-VISTA antibody) alone or in combination with cemiplimab in patients with advanced solid tumors. This is an ASCO ...

MajesTEC-9: A randomized phase 3 study of teclistamab versus pomalidomide, bortezomib, and dexamethasone or carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma. This is ...

The dream of taming IL-2 keeps slipping further away. After seeing Bristol Myers Squibb and Nektar Therapeutics give up on their candidate, Sanofi has reported “lower than projected” efficacy data on ...

Launched about eight years ago as a continuation of the iconic IL-2 Sturmovik series, IL-Sturmovik: Battle of Stalingrad received more than two dozen pieces of new content that added a plethora of ...

“[Bempegaldesleukin] was a flawed molecule, and we should not give up on IL-2 because of its rather unsurprising failure,” says Stanford University structural biologist K. Christopher Garcia, whose ...